but it wouldn't be the holidays without Blueprint Ventures' Gary Snoman.
For those unfamiliar with Gary, his earlier work.
skip to main |
skip to sidebar
Blog Archive
-
▼
2007
(182)
-
▼
December
(32)
- While We Weren't Blogging
- Yule Blog: The Virtual Are Only Virtuous Thanks to...
- While You Were Hanging Your Stockings By the Chimn...
- Deals of the Week: The Christmas Edition
- Paying the TLR Toll
- A Note on Nanotech and Cancer Diagnostics
- A bit techy yes...
- An Ugly Divorce: Where Will David Kessler Land?
- While You Were Snowed Under
- Deals of the Week: Beyond Biogen
- Biogen Idec and Carl Icant: A Report Card on Share...
- The Hope and Challenge of Personalized HealthCare
- The Lucentis/Avastin Investigation: “The Story is ...
- So What's Next for Biogen?
- Finding Common Ground on Off-Label Promotion
- ENHANCE Interrogation Technique
- Pfizer Supply Deal Ups Pressure on UK Price Cuts
- REVA's a Keeper
- Venturing to Washington II: Fleecing the Drug Indu...
- Here's Looking at You, Barry
- Drug Safety Alarm: "Something Big" Coming?
- Venturing to Washington I: The Satanic Verses
- While You Were at ASH
- We Hardly Knew Ye, MGI
- Cat Ladies, Your Misunderstood Appendix, and "Lap ...
- Deals of the Week: It's the End of the World as We...
- Pelikan Scoops up a Pouchful of Cash
- "FDA Doesn't Have to Follow the Panel's Recommenda...
- A Precision Move
- A NICE New Business: Fee-for-Advice
- Prasugrel: Lilly Tries to Stop the Bleeding (Part 2)
- While You Were Dealing
-
▼
December
(32)
Followers
Total Pageviews